Sign inJoin waitlistJoin the waitlist

Baldassarre Stea

Clinical Medical Director, Radiation Oncology · University of Arizona College of Medicine-Tucson

Credentials: · · · ·

History

Radiation Oncology · University of Arizona College of Medicine-Tucson
Present
Radiation Oncology · University of Arizona College of Medicine-Tucson
Present
University of Arizona College of Medicine-Tucson
Present

Radiology-Diagnostic
University of Arizona College of Medicine-Tucson
2018–2023
Radiation Oncology
University of Arizona College of Medicine-Tucson
1984–1988
Preliminary or Transitional Year
1983–1984
University of California, Los Angeles, Biochemistry
George Washington University Medical School
1979–1983

Research

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001
Journal of Clinical Oncology · 2020 · 677 citations
Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer
Journal of Clinical Oncology · 2013 · Last of 18 authors · 320 citations
Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications
Systematic review or meta-analysis · Radiotherapy and Oncology · 2010 · 282 citations

JC
James Cassady
12 papers
Allan Hamilton
8 papers
Abhay Sanan
5 papers
John Suh
5 papers
David Shimm
4 papers
ES
Edward Shaw
4 papers
Emmanuel Katsanis
4 papers
James Welsh
4 papers · 3 as a resident
Uma Goyal
4 papers · 4 as a resident
AS
Andrew Shetter
3 papers
Christopher Morrison
3 papers · 2 as a resident
Daruka Mahadevan
3 papers

Grants

Randomized Prospective Phase II Clinical Trial of NVX-108 in Association with Chemoradiation of Glioblastoma
National Cancer Institute · R44
PI · $2.5M · Nuvox Pharma, Llc
2010–2024
Biomedical Research Support
National Center for Research Resources · S07
Project lead · University of Arizona

Clinical trials

S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma
Study chair · Completed · Phase 2
SWOG Cancer Research Network
2004–2015
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
Site PI · Recruiting · Phase 3
Canadian Cancer Trials Group
2018–2027
Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Site PI · Unknown · Phase 2
Mitos Pharmaceuticals
2008–2010